Rifampicin-Resistant Mycobacterium tuberculosis Among Patients with Presumptive Tuberculosis in Addis Ababa, Ethiopia

References

• World Health Organization. Global Tuberculosis Report 2017. Geneva: World Health Organization; 2017.
   Google Scholar
• Banuls AL, Sanou A, Van Anh NT, Godreuil S. Mycobacterium tuberculosis: ecology and evolution of a human bacterium. J Med Microbiol. 2015;64(11):1261–1269. doi:10.1099/jmm.0.00017126385049
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global Tuberculosis Report 2019. Switzerland Geneva: WHO; 2019.
   Google Scholar
• World Health Organization. Global Tuberculosis Report 2016. Geneva: World Health Organization; 2016.
   Google Scholar
• World Health Organization. Rapid Implementation of the Xpert MTB/RIF Diagnostic Test: Technical and Operational ‘How-To’; Practical Considerations. Geneva: WHO; 2011.
   Google Scholar
• World Health Organization. Global Tuberculosis Report 18. Geneva: World Health Organization; 2018.
   Google Scholar
• Vassall A, van Kampen S, Sohn H, et al. Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis. PLoS Med. 2011;8(11):e1001120. doi:10.1371/journal.pmed.100112022087078
   PubMed Web of Science ®Google Scholar
• Hamusse SD, Teshome D, Hussen MS, Demissie M, Lindtjorn B. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia. BMC Public Health. 2016;16:593. doi:10.1186/s12889-016-3210-y27430266
   PubMed Web of Science ®Google Scholar
• Mulisa G, Workneh T, Hordofa N, Suaudi M, Abebe G, Jarso G. Multidrug-resistant Mycobacterium tuberculosis and associated risk factors in Oromia Region of Ethiopia. Int J Infect Dis. 2015;39:57–61. doi:10.1016/j.ijid.2015.08.01326327121
   PubMed Web of Science ®Google Scholar
• Girum T, Muktar E, Lentiro K, Wondiye H, Shewangizaw M. Epidemiology of multidrug-resistant tuberculosis (MDR-TB) in Ethiopia: a systematic review and meta-analysis of the prevalence, determinants and treatment outcome. Trop Dis Travel Med Vaccines. 2018;4:5. doi:10.1186/s40794-018-0065-529942536
   PubMedGoogle Scholar
• Eshetie S, Gizachew M, Dagnew M, et al. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis. BMC Infect Dis. 2017;17(1):219. doi:10.1186/s12879-017-2323-y28320336
   PubMed Web of Science ®Google Scholar
• Gebretsadik D, Ahmed N, Kebede E, Mohammed M, Belete MA. Prevalence of tuberculosis by automated GeneXpert rifampicin assay and associated risk factors among presumptive pulmonary tuberculosis patients at Ataye District Hospital, North East Ethiopia. Infect Drug Resist. 2020;13:1507–1516. doi:10.2147/IDR.S24805932547120
   PubMed Web of Science ®Google Scholar
• Gelaw SM. Socioeconomic factors associated with knowledge on tuberculosis among adults in Ethiopia. Tuberc Res Treat. 2016;2016:6207457.26949546
   PubMedGoogle Scholar
• Ministry of Health, Ethiopian Public Health Institute. ImplementatIon GuIdelIne for GeneXpert Mtb/Rif Assay in ethIopIa. Addis Ababa; 2014.
   Google Scholar
• Arega B, Menbere F, Getachew Y. Prevalence of rifampicin resistant Mycobacterium tuberculosis among presumptive tuberculosis patients in selected governmental hospitals in Addis Ababa, Ethiopia. BMC Infect Dis. 2019;19(1):307. doi:10.1186/s12879-019-3943-130947695
   PubMed Web of Science ®Google Scholar
• Ejeta E, Beyene G, Bonsa Z, Abebe G. Xpert MTB/RIF assay for the diagnosis of mycobacterium tuberculosis and rifampicin resistance in high human immunodeficiency virus setting in Gambella regional state, southwest Ethiopia. J Clin Tuberc Other Mycobact Dis. 2018;12:14–20. doi:10.1016/j.jctube.2018.06.00231720393
   PubMedGoogle Scholar
• Mekonnen D, Derbie A, Desalegn E. TB/HIV co-infections and associated factors among patients on directly observed treatment short course in Northeastern Ethiopia: a 4 years retrospective study. BMC Res Notes. 2015;8:666. doi:10.1186/s13104-015-1664-026559922
   PubMedGoogle Scholar
• Shrestha P, Arjyal A, Caws M, et al. The Application of GeneXpert MTB/RIF for smear-negative TB diagnosis as a fee-paying service at a South Asian General Hospital. Tuberc Res Treat. 2015;2015:102430.25949825
   PubMedGoogle Scholar
• Aliyu G, El-Kamary SS, Abimiku A, et al. Mycobacterial etiology of pulmonary tuberculosis and association with HIV Infection and multidrug resistance in Northern Nigeria. Tuberc Res Treat. 2013;2013:650561.23970967
   PubMedGoogle Scholar
• Alvarez-Uria G, Azcona JM, Midde M, Naik PK, Reddy S, Reddy R. Rapid diagnosis of pulmonary and extrapulmonary tuberculosis in HIV-infected patients. Comparison of LED fluorescent microscopy and the GeneXpert MTB/RIF assay in a District Hospital in India. Tuberc Res Treat. 2012;2012:932862.22966426
   PubMedGoogle Scholar
• Cox HS, Mbhele S, Mohess N, et al. Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial. PLoS Med. 2014;11(11):e1001760. doi:10.1371/journal.pmed.100176025423041
   PubMed Web of Science ®Google Scholar
• Adejumo OA, Olusola-Faleye B, Adepoju V, et al. Prevalence of rifampicin resistant tuberculosis and associated factors among presumptive tuberculosis patients in a secondary referral hospital in Lagos Nigeria. Afr Health Sci. 2018;18(3):472–478. doi:10.4314/ahs.v18i3.230602977
   PubMed Web of Science ®Google Scholar
• Datiko DG, Lindtjorn B. Tuberculosis recurrence in smear-positive patients cured under DOTS in southern Ethiopia: retrospective cohort study. BMC Public Health. 2009;9:348. doi:10.1186/1471-2458-9-34819765291
   PubMed Web of Science ®Google Scholar
• Jaleta KN, Gizachew M, Gelaw B, Tesfa H, Getaneh A, Biadgo B. Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia. Infect Drug Resist. 2017;10:185–192. doi:10.2147/IDR.S13593528652786
   PubMed Web of Science ®Google Scholar
• Jetan CA, Jamaiah I, Rohela M, Nissapatorn V. Tuberculosis: an Eight Year (2000–2007) Retrospective Study at the University of Malaya Medical Centre (Ummc), Kuala Lumpur, Malaysia. Southeast Asian J Trop Med Public Health. 2010;41(2):378–384.20578521
   PubMed Web of Science ®Google Scholar
• Nhamoyebonde S, Leslie A. Biological differences between the sexes and susceptibility to tuberculosis. J Infect Dis. 2014;209(suppl 3):S100–S6. doi:10.1093/infdis/jiu14724966189
   PubMed Web of Science ®Google Scholar
• Ramos JM, Pérez-Butragueño M, Tesfamariam A, et al. Comparing tuberculosis in children aged under 5 versus 5 to 14 years old in a rural hospital in southern Ethiopia: an 18-year retrospective cross-sectional study. BMC Public Health 2019;19(1):856. Published 2019 Jul 2. doi:10.1186/s12889-019-7206-2.
   Google Scholar
• Dodd PJ, Gardiner E, Coghlan R, Seddon JA. Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study. Lancet Glob Health. 2014;2(8):e453–e9. doi:10.1016/S2214-109X(14)70245-125103518
   PubMed Web of Science ®Google Scholar
• Nelson LJ, Wells CD. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis. 2004;8(5):636–647.15137548
   PubMed Web of Science ®Google Scholar
• Tilahun G, Gebre-Selassie S. Treatment outcomes of childhood tuberculosis in Addis Ababa: a five-year retrospective analysis. BMC Public Health. 2016;16:612. doi:10.1186/s12889-016-3193-827443308
   PubMed Web of Science ®Google Scholar
• Mirutse G, Fang M, Kahsay AB, Ma X. Epidemiology of childhood tuberculosis and factors associated with unsuccessful treatment outcomes in Tigray, Ethiopia: a ten-year retrospective cross sectional study. BMC Public Health. 2019;19(1367):1–7. doi:10.1186/s12889-019-7732-y30606151
   PubMed Web of Science ®Google Scholar
• Dangisso MH, Datiko DG, Lindtjorn B. Low case notification rates of childhood tuberculosis in southern Ethiopia. BMC Pediatr. 2015;15:142. doi:10.1186/s12887-015-0461-126428086
   PubMed Web of Science ®Google Scholar
• Mulu W, Abera B, Yimer M, Hailu T, Ayele H, Abate D. Rifampicin-resistance pattern of Mycobacterium tuberculosis and associated factors among presumptive tuberculosis patients referred to Debre Markos Referral Hospital, Ethiopia: a cross-sectional study. BMC Res Notes. 2017;10(1):8. doi:10.1186/s13104-016-2328-428057041
   PubMedGoogle Scholar
• Ramos JM, Fernandez Munoz M, Tisiano G, et al. Use of Xpert MTB/RIF assay in rural health facilities in Southern Ethiopia. Arch Clin Microbiol. 2018;09(01). doi:10.4172/1989-8436.100077.
   Google Scholar
• UNAIDS. UNAIDS Data 2019. Geneva, Switzerland: UNAIDS Joint United Nations Programme on HIV/AIDS; 2019.
   Google Scholar
• Teweldemedhin M, Asres N, Gebreyesus H, Asgedom SW. Tuberculosis-Human Immunodeficiency Virus (HIV) co-infection in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2018;18(1):676. doi:10.1186/s12879-018-3604-930563476
   PubMed Web of Science ®Google Scholar
• Okonkwo R, Onwunzo M, Chukwuka C, et al. The use of the Gene Xpert mycobacterium tuberculosis/Rifampicin (MTB/Rif) assay in detection of multi-drug resistant tuberculosis (MDRTB) in Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria. J HIV Retro Virus. 2017;3(1):1–5.
   Google Scholar
• Nyang’au LO, Amukoyeb E, Ng’ang’a Z. Determining first line anti-tuberculosis drug resistance among new and re-treatment tuberculosis/human immunodeficiency virus infected patients, Nairobi Kenya. Int J Sci Basic Appl Res. 2015;19(2):426–437.
   Google Scholar
• Mesfin EA, Beyene D, Tesfaye A, et al. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia. PLoS One. 2018;13(6):e0197737. doi:10.1371/journal.pone.019773729864118
   PubMed Web of Science ®Google Scholar
• Hordofa MW. Prevalence of refampcin mono resistant mycobacterium tuberculosis among suspected cases attending at Yirgalem Hospital. Clin Med Res. 2015;4(3):75. doi:10.11648/j.cmr.20150403.13
   Google Scholar
• Gebrehiwet GB, Kahsay AG, Welekidan LN, Hagos AK, Abay GK, Hagos DG. Rifampicin resistant tuberculosis in presumptive pulmonary tuberculosis cases in Dubti Hospital, Afar, Ethiopia. J Infect Dev Ctries. 2019;13(1):21–27. doi:10.3855/jidc.1046232032019
   PubMed Web of Science ®Google Scholar
• Seyoum B, Demissie M, Worku A, Bekele S, Aseffa A. Prevalence and drug resistance patterns of mycobacterium tuberculosis among new smear positive pulmonary tuberculosis patients in Eastern Ethiopia. Tuberc Res Treat. 2014;2014:753492.24834351
   PubMedGoogle Scholar
• Adane K, Ameni G, Bekele S, Abebe M, Aseffa A. Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia. BMC Public Health. 2015;15:572. doi:10.1186/s12889-015-1933-926092570
   PubMed Web of Science ®Google Scholar
• Odone A, Calderon R, Becerra MC, et al. Acquired and transmitted multidrug resistant tuberculosis: the role of social determinants. PLoS One. 2016;11(1):e0146642. doi:10.1371/journal.pone.014664226765328
   PubMed Web of Science ®Google Scholar
• Biadglegne F, Sack U, Rodloff AC. Multidrug-resistant tuberculosis in Ethiopia: efforts to expand diagnostic services, treatment and care. Antimicrob Resist Infect Control. 2014;3(31):1–10. doi:10.1186/2047-2994-3-31
   Web of Science ®Google Scholar
• Abdella K, Abdissa K, Kebede W, Abebe G. Drug resistance patterns of Mycobacterium tuberculosis complex and associated factors among retreatment cases around Jimma, Southwest Ethiopia. BMC Public Health. 2015;15:599. doi:10.1186/s12889-015-1955-326135909
   PubMed Web of Science ®Google Scholar
• Abate D, Taye B, Abseno M, Biadgilign S. Epidemiology of anti-tuberculosis drug resistance patterns and trends in tuberculosis referral hospital in Addis Ababa, Ethiopia. BMC Res Notes. 2012;5:462. doi:10.1186/1756-0500-5-46222929063
   PubMedGoogle Scholar
• Hirpa S, Medhin G, Girma B, et al. Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study. BMC Public Health. 2013;13(782):1–9. doi:10.1186/1471-2458-13-78223280303
   PubMed Web of Science ®Google Scholar
• Deressa MA, Demissie M. Risk factors of multi-drug resistant tuberculosis in Addis Ababa, Ethiopia: a matched case-control study. OALib. 2014;01(03):1–8. doi:10.4236/oalib.1100489
   Google Scholar
• Ethiopian Food Medicine and Healthcare Administration and Control Authority. Strategy for the Prevention and Containment of Antimicrobial Resistance for Ethiopia. Addis Ababa, Ethiopia; 2015.
   Google Scholar
• Ethiopian Food MaHAaCA. A Practical Guide to Antimicrobial Stewardship Program in Ethiopian Hospitals. Addis Ababa, Ethiopia; 2018.
   Google Scholar
• Shargie EB, Lindtjorn B. DOTS improves treatment outcomes and service coverage for tuberculosis in South Ethiopia: a retrospective trend analysis. BMC Public Health. 2005;5:62. doi:10.1186/1471-2458-5-6215938746
   PubMed Web of Science ®Google Scholar
• Geleta DA, Megerssa YC, Gudeta AN, Akalu GT, Debele MT, Tulu KD. Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility. BMC Microbiol. 2015;15:220. doi:10.1186/s12866-015-0566-626483194
   PubMed Web of Science ®Google Scholar